000 | 01189 a2200325 4500 | ||
---|---|---|---|
005 | 20250517234841.0 | ||
264 | 0 | _c20191218 | |
008 | 201912s 0 0 eng d | ||
022 | _a1875-6417 | ||
024 | 7 |
_a10.2174/1573399814666180903162556 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRana, Divya | |
245 | 0 | 0 |
_aIs there a Role for Sodium Orthovanadate in the Treatment of Diabetes? _h[electronic resource] |
260 |
_bCurrent diabetes reviews _c2019 |
||
300 |
_a284-287 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEnzyme Inhibitors _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xchemistry |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProtein Tyrosine Phosphatase, Non-Receptor Type 1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aVanadates _xpharmacology |
700 | 1 | _aKumar, Anoop | |
773 | 0 |
_tCurrent diabetes reviews _gvol. 15 _gno. 4 _gp. 284-287 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/1573399814666180903162556 _zAvailable from publisher's website |
999 |
_c28800062 _d28800062 |